US Stock MarketDetailed Quotes

ANVS Annovis Bio

Watchlist
  • 8.870
  • +0.400+4.72%
Close 03/01 16:00 ET
  • 8.990
  • +0.120+1.35%
Post 17:07 ET
93.84MMarket Cap-1832P/E (TTM)

About Annovis Bio Company

Annovis Bio, Inc. is a clinical stage drug platform company, which engages in the development of drugs which aims to treat neurodegenerative diseases such as Alzheimer's (AD) and Parkinson's (PD). Its lead product candidate, Buntanetap, is designed to address AD, PD, and potentially other chronic neurodegenerative diseases. Its product pipeline also includes ANVS405 and ANVS301, which focus on the treatment of traumatic brain injury, stroke, and advanced AD. The company was founded by Maria Luisa Maccecchini in May 2008 and is headquartered in Berwyn, PA.

Company Profile

SymbolANVS
Company NameAnnovis Bio
Listing Date01/29/2020
Issue Price6.00
Founded2008
CEODr. Maria Maccecchini, PhD
MarketNYSE
Employees5
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1055 Westlakes Drive,Suite 300
CityBerwyn
ProvincePennsylvania
CountryUnited States of America
Zip Code19312
Phone1-610-727-3913

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Maria Maccecchini, PhD
  • Director, President and Chief Executive Officer
  • 2.65M
  • Henry Hagopian
  • Chief Financial Officer and Principal Accounting Officer
  • 1.42M
  • Michael M.B. Hoffman
  • Chairman of the Board
  • 147.41K
  • Dr. Claudine E. Bruck, PhD
  • Independent Director
  • 131.03K
  • Mark White
  • Independent Director
  • 131.03K
  • Reid S. McCarthy
  • Independent Director
  • 131.03K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg